It is a useful stewardship tool that did not increase the risk of complications for patients with respiratory and urinary tract infections.39,75–77 Point-of-care diagnostics tests were used to detect biomarkers of bacterial infection including CRP and procalcitonin using blood samples, as well as to diagnose urinary tract infections using urine dipstick tests, and respiratory viruses via rapid molecular testing platforms. The gene discussed is CRP; the disease is urinary tract infection.